About
Immunotherapies targeting Tregs
Areas of Focus
Categories
Biologics & Biopharmaceutical
Team (6)
Bernard Vanhove Ph.D
Chief Development Officer
Egle Therapeutics
team_member
Fiorella Kotsias DVM, PhD
Chief Scientific Officer
Egle Therapeutics
executive
Jean-Philippe DEL
Chief Financial Officer
Egle Therapeutics
executive
Pejvack Motlagh MD, MSc
Chief Medical Officer
Egle Therapeutics
executive
Reno Winter Ph.D
Chief Technical Officer
Egle Therapeutics
team_member
Vincent Brichard
Chief Executive Officer
Egle Therapeutics
executive
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
50
By Phase
PHASE1/PHASE2: 1
By Status
RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Locations (1)
Headquarters
Paris, France
Map
Loading map...